These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22209051)

  • 1. The potential role of microRNA-146 in Alzheimer's disease: biomarker or therapeutic target?
    Wang LL; Huang Y; Wang G; Chen SD
    Med Hypotheses; 2012 Mar; 78(3):398-401. PubMed ID: 22209051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased microRNA-146a/b, TRAF6 gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sjögren's syndrome.
    Zilahi E; Tarr T; Papp G; Griger Z; Sipka S; Zeher M
    Immunol Lett; 2012 Jan; 141(2):165-8. PubMed ID: 22033216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-induced microRNA-146a represses Bcl-2 through Traf6/IRAK1 but not Smad4 to promote chondrocyte autophagy.
    Chen G; Gao X; Wang J; Yang C; Wang Y; Liu Y; Zou W; Liu T
    Biol Chem; 2017 Apr; 398(4):499-507. PubMed ID: 27845876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-146a Contributes to SCI Recovery via Regulating
    Wei J; Wang J; Zhou Y; Yan S; Li K; Lin H
    Biomed Res Int; 2016; 2016():4013487. PubMed ID: 27830143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MyD88, IRAK1 and TRAF6 knockdown in human chondrocytes inhibits interleukin-1-induced matrix metalloproteinase-13 gene expression and promoter activity by impairing MAP kinase activation.
    Ahmad R; Sylvester J; Zafarullah M
    Cell Signal; 2007 Dec; 19(12):2549-57. PubMed ID: 17905570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NeurimmiRs: microRNAs in the neuroimmune interface.
    Soreq H; Wolf Y
    Trends Mol Med; 2011 Oct; 17(10):548-55. PubMed ID: 21813326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling.
    Colangelo V; Schurr J; Ball MJ; Pelaez RP; Bazan NG; Lukiw WJ
    J Neurosci Res; 2002 Nov; 70(3):462-73. PubMed ID: 12391607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the kynurenine pathway as a potential strategy to prevent and treat Alzheimer's disease.
    Gong CY; Li Z; Wang HM; Liu J; Chen L; Zhang HW; Wang X; Yang J
    Med Hypotheses; 2011 Sep; 77(3):383-5. PubMed ID: 21683531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies in patients with Alzheimer's disease: pathogenetic role and potential use as biomarkers of disease progression.
    Colasanti T; Barbati C; Rosano G; Malorni W; Ortona E
    Autoimmun Rev; 2010 Oct; 9(12):807-11. PubMed ID: 20656067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase C as a peripheral biomarker for Alzheimer's disease.
    de Barry J; Liégeois CM; Janoshazi A
    Exp Gerontol; 2010 Jan; 45(1):64-9. PubMed ID: 19895879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BACE: Therapeutic target and potential biomarker for Alzheimer's disease.
    Evin G; Barakat A; Masters CL
    Int J Biochem Cell Biol; 2010 Dec; 42(12):1923-6. PubMed ID: 20817005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation.
    Wang X; Liu P; Zhu H; Xu Y; Ma C; Dai X; Huang L; Liu Y; Zhang L; Qin C
    Brain Res Bull; 2009 Oct; 80(4-5):268-73. PubMed ID: 19683563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-18 stimulates fibronectin expression in primary human cardiac fibroblasts via PI3K-Akt-dependent NF-kappaB activation.
    Reddy VS; Harskamp RE; van Ginkel MW; Calhoon J; Baisden CE; Kim IS; Valente AJ; Chandrasekar B
    J Cell Physiol; 2008 Jun; 215(3):697-707. PubMed ID: 18064631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of microRNA-155 in autoimmunity.
    Leng RX; Pan HF; Qin WZ; Chen GM; Ye DQ
    Cytokine Growth Factor Rev; 2011 Jun; 22(3):141-7. PubMed ID: 21703910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory therapy in Alzheimer's disease: is hope still alive?
    van Gool WA; Aisen PS; Eikelenboom P
    J Neurol; 2003 Jul; 250(7):788-92. PubMed ID: 12883918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of interleukin-1 receptor-associated kinase 1 as a critical component that induces post-transcriptional activation of IκB-ζ.
    Ohba T; Ariga Y; Maruyama T; Truong NK; Inoue J; Muta T
    FEBS J; 2012 Jan; 279(2):211-22. PubMed ID: 22059479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candidate genes for late-onset Alzheimer's disease: focus on chromosome 12.
    Panza F; Colacicco AM; D'Introno A; Capurso C; Liaci M; Capurso SA; Capurso A; Solfrizzi V
    Mech Ageing Dev; 2006 Jan; 127(1):36-47. PubMed ID: 16183100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum or cerebrospinal fluid levels of glyceraldehyde-derived advanced glycation end products (AGEs) may be a promising biomarker for early detection of Alzheimer's disease.
    Yamagishi S; Nakamura K; Inoue H; Kikuchi S; Takeuchi M
    Med Hypotheses; 2005; 64(6):1205-7. PubMed ID: 15823718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma aminothiol compounds, but not serum tumor necrosis factor receptor II and soluble receptor for advanced glycation end products, are related to the cognitive impairment in Alzheimer's disease and mild cognitive impairment patients.
    Hernanz A; De la Fuente M; Navarro M; Frank A
    Neuroimmunomodulation; 2007; 14(3-4):163-7. PubMed ID: 18073509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated butyrylcholinesterase and acetylcholinesterase may predict the development of type 2 diabetes mellitus and Alzheimer's disease.
    Rao AA; Sridhar GR; Das UN
    Med Hypotheses; 2007; 69(6):1272-6. PubMed ID: 17553629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.